·威尔布兰德因子调节免疫复合体和反召反应对因子VIII在小鼠血友病A型模型
Olga Oleshko1, Nadine Vollack-Hesse1, Andreas Tiede1
1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Blood advances
|September 27, 2023
概括
·威尔布兰德因子 (VWF) 可以降低血液过敏症A (HA) 小鼠对因子VIII (FVIII) 的免疫反应. 将VWF纳入免疫复合体限制了它们的有害影响,并抑制了FVIII特异性的召回反应.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 生物化学 生物化学
背景情况:
- 实现对第八因子 (FVIII) 的免疫耐受性对于治疗血友病A (HA) 是至关重要的.
- 在高达40%的严重HA患者中,对FVIII产生中和抗体.
- 免疫耐受性诱导疗法需要长时间注射FVIII.
研究的目的:
- 调查·威尔布兰德因子 (VWF) 在调节抗FVIII抗体效应因子功能的作用.
- 在A型血友病小鼠模型中评估VWF对FVIII特异性回忆反应的影响.
主要方法:
- 分析超离心以检测含有FVIII的免疫复合体 (FVIII-ICs).
- 试验室试验评估VWF对FVIII-IC结合的作用,以补充C1q,Fc-γ受体和树突细胞.
- 在体外和体外模型来评估FVIII特定的回忆反应.
主要成果:
- VWF被纳入了具有FVIII和抗体的更大的宏分子复合体,而不是完全防止FVIII-IC的形成.
- VWF抑制了FVIII-IC结合,以补充C1q,Fc-γ受体和树突细胞.
- 在体外,VWF消除了FVIII特异性抗体分泌细胞的增殖,并在体内减少了FVIII回忆反应.
结论:
- VWF调节FVIII-ICs的形成和效应器功能.
- 在A型血友病小鼠中,VWF减弱了对FVIII的二次免疫反应.
- 这些发现表明VWF在改善FVIII耐受性策略方面可能发挥作用.
更多相关视频
08:30Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
11.3K
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
14.2K
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.2K